(P)
423 South PalmPecos, TX 79772
(915) 445-9090
AC,AU,CT,FP,NT,PM
Plano
Linda Martin, D.O. (P)
Suite C
1524 Independence
Plano, TX 75075
(214) 985-1377
FAX (214) 612-0747
CT,GP,NT,PM
San Antonio
Jim P. Archer, D.O. (P)
8434 Fredericksburg Road
San Antonio, TX 78229
(512) 615-8445
A,CT,HO,NT,PM
Ron Stogryn, M.D. (P)
Suite 100
7334 Blanco Road
San Antonio, TX 78216
(512) 366-3637
FAX (512) 366-3638
A,CT,MM,NT,PD,YS
Wichita Falls
Thomas R. Humphrey, M.D. (P)
2400 Rushing
Wichita Falls, TX 76308
(817) 766-4329
BA,FP,GP,HYP
UTAHProvo
Dennis Harper, D.O. (D/C)
Suite 11E
1675 North Freedom Boulevard
Provo, UT 84604
(801) 373-8500
A,CT,OSM,YS
D. Remington, M.D. (D/C)
Suite 11E
1675 North Freedom Boulevard
Provo, UT 84604
(801) 373-8500
A,CT,EM,FP
VIRGINIA
Annandale
Sohini Patei, M.D. (P)
Suite 207
7023 Little River Turnpike
Annandale, VA 22003
(703) 941-3606
A,CT,NT,PM
Hinton
Harold Huffman, M.D. (D/C)
PO Box 197
Hinton, VA 22831
(703) 867-5242
CT,FP,PM
Midlothian
Peter C. Gent, D.O. (D/C)
11900 Hull Street
Midlothian, VA 23112
(804) 744-3551CT,GP,OSM
Norfolk
Vincent Speckhart, M.D. (DIPL)
902 Graydon Avenue
Norfolk, VA 23507
(804) 622-0014
IM,Medical Oncology
Trout Dale
Elmer M. Cranton, M.D., F.A.C.A.M. (DIPL)
Ripshin Road, Box 44
Trout Dale, VA 24378
(703) 677-3631
FAX (703) 677-3843
A,CD,CT,FP,HO,NT
WASHINGTON
Bellevue
David Buscher, M.D. (P)
Suite 102
1370 - 116th NE
Bellevue, WA 98004-3825
(206) 453-0288
Clinical Ecology/EM,GP,NT
Maurice Stephens, M.D. 5011 133rd Place SE
Bellevue, WA 98006
(No Referrals)
Bellingham
Robert Kimmel, M.D. (D/C)
Suite 104
4204 Meridian
Bellingham, WA 98226(206) 734-3250
AC,CT,DD,FP,NT,PM
Fairchild
James P. De Santis, D.O. 8116 Palm Street
Fairchild AFB, WA 99011
(No Referrals)
Kent
Jonathan Wright, M.D. (P)
24030 - 132nd, SE
Kent, WA 98042
(206) 631-8920
A,CT,END,FP,MM,NT
Kirkland
Jonathan Collin, M.D. (DIPL)
Suite A-50
12911 120th Avenue NE
PO Box 8099
Kirkland, WA 98034
(206) 820-0547
FAX (206) 385-7703
CT,NT,PM
Port Townsend
Jonathan Collin, M.D. (DIPL)
911 Tyler Street
Port Townsend, WA 98368
(206) 385-4555
CT,NT,PM
Seattle
Michael G. Vesselago, M.D. (P)
217 North 125th
Seattle, WA 98133(206) 367-0760
CT,FP,IM,MM,NT,PM
Spokane
Burton B. Hart, D.O. (P)
East 12104 Main
Spokane, WA 99206
(509) 927-9922
FAX (509) 927-9922
CT,OSM,PM
Vancouver
Richard P. Huemer, M.D. (P)
Building C-303
406 SE 131st Avenue
Vancouver, WA 98684
(206) 253-4445
A,CT,HGL,MM,NT,PM
Yakima
Murray L. Black, D.O. (P)
609 South 48th Avenue
Yakima, WA 98906
(509) 966-1780
A,CT,FP,GP,OSM
Yeim
Elmer M. Cranton, M.D., F.A.C.A.M. (DIPL)
15246 Leona Drive SE
Yeim, WA 98597
(206) 894-3548
FAX (206) 894-2176
A,CD,CT,FP,HO,NT
WEST VIRGINIA
BeckleyPrudencio Corro, M.D. (P)
251 Stanaford Road
Beckley, WV 25801
(304) 252-0775
A,CT,RHI
Michael Kostenko, D.O. (DIPL)
114 East Main Street
Beckley, WV 25801
(304) 253-0591
A,AC,CT,FP,OSM,PM
Charleston
Steve M. Zekan, M.D. (P)
1208 Kanawha Boulevard East
Charleston, WV 25301
(304) 343-7559
CT,NT,PM,S
WISCONSIN
Green Bay
Eleazar M. Kadile, M.D. (D/C)
1538 Bellevue Street
Green Bay, WI 54311
(414) 468-9442
A,CT,P
Lake Geneva
Rathna Alwa, M.D. (DIPL)
717 Geneva Street
Lake Geneva, WI 53147
(414) 248-1430
AC,AR,BA,CT,HYP,IM
Milwaukee
William J. Faber, D.O. (P)6529 West Fond du Lac Avenue
Milwaukee, WI 53218
(414) 464-7680
Neuro-Musculoskeletal
Thomas Hesselink, M.D. (D/C)
Suite 202
10520 West Blue Mound Road
Milwaukee, WI 53226
(414) 259-1350
A,Candida,CT,GP,NT,PM
Robert R. Stocker, D.O. (DIPL)
2505 Mayfair Road
Milwaukee, WI 53226
(Retired)
Jerry N. Yee, D.O. (D/C)
2505 North Mayfair Road
Milwaukee, WI 53226
(414) 258-6282
BA,CT,GP,OSM
Wisconsin Dells
Robert S. Waters, M.D. (DIPL)
Race and Vine Streets
Box 357
Wisconsin Dells, WI 53965
(608) 254-7178
CT,OME,PM
American College of Advancement in Medicine
(ACAM) Physicians—InternationalAUSTRALIA
Donvale, Victoria
R.B. Allen, M.D. (D/C)
5/90 Mitcham Road
Donvale, Victoria 3111
A,AC,CT,HGL,NT,PM
Gosford, N.S.W. Heather M. Bassett, M.D. (P)
91 Donnison Street
Gosford, N.S.W. 2250
CD,DD,GYN,NT,OSM,PMR
BELGIUM
Antwerpen
Didier Langouche, M.D. (D/C)
Rubenslei 17
2018 Antwerpen
CT
Ghent
Michel De Meyer, M.D. (D/C)
Nekkersberglaan 11
9000 Ghent
FP,GP,OS,PH
St. Niklaas
A. De Bruyne, M.D. (D/C)
Ankerstraat 152B
2700 St. Niklaas
DD,FP,GER,GP,OBS,PM
BRAZIL
AmazonasFernando M. de Souza, M.D. (P)
R. Fortaleza 203
Adrianopolis, Manaus
Amazonas CEP 69050
CT,NT,PM
Curitiba
Oslim Malina, M.D. (P)
Rua Casemiro de Abreu 32
Curitiba, PR
Brazil 82.000
CT,Vascular Surgery
Florianopolis
Jose P. Figueredo, M.D. (P)
PCA Geturio Vargas, 20
Florianopolis, SC
CD,CT,GER,IM,NT,PM
Osorio-RS
Jose Valdai de Souza, M.D. (P)
St. Mal Floriano 1012
s/Iron 1 to 9
Osorio-RS 95520
CD,CT,DD,GER,GP,PM
Pelotas-RS
Antonio C. Fernandes, M.D. (P)
Rua Santa Tecia 470A
Pelotas, RS 96010
CD,CT,GER,GP,IM,PM
Porto Alegre
Moyses Hodara, M.D. (P)
Rua Vigario Jose Inacio
368, Sala 102
Porto Alegre-RSCS,CT,DD,FP,GP,RHU
Carlos J.P. de Sa, M.D. (P)
Marcilio Dias-1056
Porto Alegre-RS 90060
CD,CT,DIA,HGL,S
Rio Preto
A.O. Passos Correa, M.D. (P)
Ave. Alberto Andalo
3314 Sao Jose do Rio Preto
CEP: 15015
CD,CT,GER,IM,NT,PM
Sao Paulo
Guilherme Deucher, M.D. (P)
Rua Borges,
Lagoa 1231/2
°
 Andares
Sao Paulo
CT,PM,S
Fernando L. Flaquer, M.D. (D/C)
Rua Prof. Artur Ramos
183y33, Sao Paulo
CS,CT,DD,GER,IM,PM
Sergio Vaisman, M.D. (P)
Rua Hilo Torres 123
Sao Paulo, SP 04650
CD,CT,DD,GER,IM,PM
CANADA
*
BRITISH COLUMBIA
*
Argenta
Robert Sweeney, M.D. (D/C)
General DeliveryArgenta, B.C. V0G 1B0
CT,P
Errington
George Barber, M.D. (D/C)
Box 234
Errington, B.C. V0R 1V0
CT,GP
Kelowna
Alex A. Neil, M.D. (D/C)
205 Rutland Road
Kelowna, B.C. V1X 3B1
CT,GP,HYP,NT
Vancouver
Kevin R. Nolan, M.D. (D/C)
205/2786 West 16th Avenue
Vancouver, B.C. V6K 3C4
A,FP,NT,PM,PO,YS
Saul Pilar, M.D. (D/C)
205/2786 West 16th Avenue
Vancouver, B.C. V6K 3C4
A,DD,HYP,NT
Donald W. Stewart, M.D. (D/C)
2184 West Broadway, #435
Vancouver, B.C. V6K 2E1
CT,GP
Zigurts Strauts, M.D. (D/C)
3077 Granville Street, #201
Vancouver, B.C. V6H 3J9
AC,CT,FP,Thermography, Manipulative Therapy
Victoria
Deanne Roberts, M.D. (P)1041 Chamberlain Street
Victoria, B.C. V8S 4C1
A,CT,NT,PM
*
MANITOBA
*
Winnipeg
Howard N. Reed, M.D. (P)
302 Lamont Boulevard
Winnipeg, Manitoba R3P 0G1
(Retired)
*
ONTARIO
*
Blythe
Richard W. Street, M.D. (D/C)
Box 100, Gypsy Lane
Blythe, Ont. N0M 1H0
GP,NT,PM
Sarnia
Nazeer Vellani, M.D. (P)
241 Wellington Street
Sarnia, Ont. N7T 1G9
CT,NT,PM
Smiths Falls
Clare Minielly, M.D. (D/C)
33 Williams Street East
Smiths Falls, Ont. K7A 1C3
AN,CT,GP,NT
Willowdale
Paul Cutler, M.D., F.A.C.A.M. (DIPL)
Suite B-4
4841 Yonge Street
Willowdale, Ont. M2N 5X2
A,CT,NTDENMARK
Aarhus
Kurt Christensen, M.D. (DIPL)
Fredenstorv 8-1
8000 Aarhus C
AC,CT,GP,NT
Bruce P. Kyle, M.D. (P)
Sydtoften 35
8260 Aarhus
CT,GP,NT,OME,PM
Humlebaek
Joergen Rugaard, M.D. (D/C)
23 Kystvej
3050 Humlebaek
Lyngby
Claus Hancke, M.D. (DIPL)
Lyngby Hovedgade 17
1
DK-2800 Lyngby
CT,FP,GP,NT,OSM,PM
Skodsborg
Bo Mogelvang, M.D. (P)
Strandvejen 123-135
DK-2942 Skodsborg
CT,NT,PM
Niels Ove Pedersen, M.D. (P)
Strandvejen 123-135
DK-2942 Skodsborg
AN,CD,CT,IM,NT,PM
Vejle
Knut T. Flytlie, M.D. (D/C)Gludsmindevej 39
DK-7100 Vejle
A,AC,AU,GP,OSM,PM
Virum
Pierre Eggers-Lura, M.D. (P)
Furesoevej 141
DK-2830 Virum
AC,CT,NT
DOMINICAN REPUBLIC
Santo Domingo
Antonio Pannocchia, M.D. (P)
Suite 201
Ave. 27 de Febrero
Santo Domingo 6
CT,NT,PM
EGYPT
Cairo
Elham G. Behery, M.D. (P)
94 Sarwat Street, Orman
Cairo
A,DIA,END,HGL,MM,RHU
ENGLAND
Kent
F. Schellander, M.D. (P)
8 Chilston Road
Tunbridge Wells
Kent TN4 9LT
CT,GP,HO,MM,NT,PM
West SussexSimi Khanna, M.D. (P)
34 St. Agnes Road
East Grinstead
West Sussex RH193RP
HOM,NT
FRANCE
Paris
Bruno Crussol, M.D. (P)
4 Rue Des Belles Feuilles
75016 Paris
CT,NT,PM,S
Paul Musarella, M.D. (D/C)
96 Rue de Miromesnil
75008 Paris
GER,NT,PM,S
GERMANY
Bad Fussing
Karl Heinz Caspers, M.D. (P)
Beethovenstrasse 1
D 8397 Bad Fussing
NT,PM
Bad Steben
Helmut Keller, M.D. (P)
Am Reuthlein 2
D 8675 Bad Steben
IM,Oncology,PD,S
Rottach-Egern
Claus Martin, M.D. (P)
PO Box 244
8183 Rottach-EgernCT,DD,GER
Werne
Jens-Ruediger Collatz, M.D. (P)
Fuerstenhofklinik
Fuerstenhof 2
D 4712 Werne
AC,CT,DD,GER,HO,PM
INDONESIA
Bandung
Benj. Widjajakusuma, M.D. (P)
Pasirkaliki 115
Bandung 40172
CD,DIA,GER,IM,NT,PUD
Jakarta
Maimunah Affandi, M.D. (DIPL)
Suite 13
Jalan Gandaria 8
Kebayoran-Baru
Jakarta-Selatan
CD,CT,DD,PD
Adjit Singh Gill, M.D. (P)
Suite 27A
Jalan Tanah Abang V
Jakarta
CD,CT,PM
Yahya Kisyanto, M.D. (DIPL)
71 Diponegoro
Jakarta
CD,CT,DIA,GER,IM,PMR
ITALYMichele Ballo, M.D. (P)
Via Ruggero Settimo, 55
90139 Palermo
CD,CT,GER,IM,PM,PMR
MALAYSIA
Mohamed S.A. Ishak, M.D. (P)
40 Jalan Kee Ann,
75100 Melaka
West Malaysia
FP,GP,RHI
MEXICO
Chihuahua
H. Berlanga Reyes, M.D. (DIPL)
Antonio de Montes 2118
Col. San Felipe
Chihuahua, Chih. 31240
CT,GER,GP,PM
Guadalajara, Jalisco
Eleazar A. Carrasco, M.D. (P)
Chapultepec Norte 140-203
Guadalajara, Jalisco 44600
CT,GP,GYN,OBS,S
F. Navares Merino, M.D. (DIPL)
Lopez Mateos Nte. 646, S.H. Guadalajara, Jalisco 44680
CT,NT,PM
Juarez, Chihuahua
H. Berlanga Reyes, M.D. (DIPL)
Insurgentes 2516
Cd. Juarez, Chihuahua 32330
CT,GER,GP,PMFrancisco Soto, M.D. (D/C)
16 de Septiembre, 2215
32030 Cd. Juarez
CD,CT,DD,HO,PM,S
Matamoros, Tamp. Frank Morales, Sr., M.D. (P)
1a y Nardos, Cal. Jardin
H. Matamoros, Tamp. CT,DD,NT,PM
Tijuana
Francisco Rique, M.D. (P)
Azucenas 15
Frac. del Prado
Tijuana, B.C. AC,AR,CT,DD,NT,PM
Rodrigo Rodriguez, M.D. (D/C)
Azucenas 15
Frac. del Prado
Tijuana, B.C. CD,CT,DD,GER,MM,PM
Roberto Tapia, M.D. (P)
Azucenas 15
Frac. del Prado
Tijuana, B.C. CT,DD,END,MM,NT,PM
Torreon, Coahuila
Carlos Lopez Moreno, M.D. (P)
Tulipanes 475
Col. Torreon, Jardin
Torreon, Coahuila 27200
CT,NT,PMNETHERLANDS
Bilthoven
C.J.M. Broekhuyse, M.D. (D/C)
Hobbemalaan 11
3723 EP Bilthoven
AC,AU,CT,DD,GP,NT,PM
Etten-Leur
Peter Zeegers, M.D. (P)
Beatrixpark 20
4872 BJ Etten-Leur
A,CD,CT,DD,GP
Haarlem
Eduard Schweden, M.D. (DIPL)
Kenaupark 22
2011 MT Haarlem
CT,DD,NT,OS,PM
Dirk van Lith, M.D. (DIPL)
Kenaupark 22
2011 MT Haarlem
A,DD,CT,GP,HO,NT,PM,S
Leende
Peter van der Schaar, M.D. (DIPL)
Renheide 2
5595 XJ Leende
CD,CT,DD,OME,S
Marc Verheyen, M.D. (DIPL)
Renheide 2
5595 XJ Leende
CD,CT,DD,OME,S
LoenerslootA. Verbon, M.D. (D/C)
Voorburgstraat 30
NL3634 AW Loenersloot
CT,PUD
Maastricht
Rob van Zandvoort, M.D. (DIPL)
Burg. Cortenstraat 26
6226 GV Maastricht
CT
Oudenbosch
E.T. Oei, M.D. (D/C)
34 St. Louis Markt
4731 HP Oudenbosch
AC,CT,DIA,END,GER,IM
Rotterdam
Robert T.H.K. Trossel, M.D. (DIPL)
Zoutmanstraat 4
3012 EV Rotterdam
A,DD,CT,GP,HO,NT,PM,S
Utrecht
P.J.C. Riethoven, M.D. (D/C)
Ramstraat 27-A
3581 HD Utrecht
CT
Velp
J.H. Leenders, M.D. (D/C)
344 Arnhemsestraatweg
6881 NK Velp
A,AC,AU,CD,CT,DD,PM
NETHERLANDS ANTILLESAruba
Adhemar E. Hart, M.D. (P)
Shakespearstraat 13
Oranjestad, Aruba
PD
St. Maarten
Dirk van Lith, M.D. (DIPL)
PO Box 3030
Simpsonbay
St. Maarten
A,CT,DD,GP,HO,NT,PM,S
Robert T.H.K. Trossel, M.D. (DIPL)
PO Box 3030
Simpsonbay, St. Maarten
A,CT,DD,GP,HO,NT,PM,S,
NEW ZEALAND
Auckland
Maurice B. Archer, D.O. (P)
PO Box 2981
Auckland 1
CT,NT,PM
R.H. Bundellu, M.D. (DIPL)
173 Tamaki Road
Otara, Auckland
CT,FP,OBS
Christchurch
Robert Blackmore, M.D. (D/C)
196 Hills Road
Christchurch 1
AC,CT,FP,GP,NT,OBSHamilton
William J. Reeder, M.D. (D/C)
PO Box 4187
Hamilton
AC,CT,GP,NT,PM
Masterton
T.J. Baily Gibson, M.D. (DIPL)
PO Box 274
Masterton
A,CT,FP,OBS,OME
New Lynn
Raymond Ramirez, M.D. (P)
3075 Great North Road
New Lynn, Auckland
AC,AU,CT,GP,OSM,YS
Napier
Tony Edwards, M.D. (D/C)
30 Munroe Street
Napier
CT,FP,NT,OBS,PM
Oxford, North Canterbury
Ted Walford, M.D. (P)
454 Cameron Road
Tauranga
CT,NT,PM
Tauranga
Michael E. Godfrey, M.D. (DIPL)
Willow House
14 Willow Street
TaurangaCT,OME,PM
PHILIPPINES
Manila
Rosa M. Ami Belli, M.D. (P)
Suite 303-501
PDC Building
1440 Taft Avenue
Manila
CT,HGL,NT,P
Leonides Lerma, M.D. (P)
#301, Pearl Garden
1700 M. Adriatico Malate
Manila
A,AC,AU,GER,P
Corazon Macawili-Yu, M.D. (P)
Suite 303-501
PDC Building
1440 Taft Avenue
Manila
CT,NT,PM
Remedios L. Reynoso, M.D. (P)
Suite 303-501
PDC Building
1440 Taft Avenue
Manila
CT,NT,PM
PUERTO RICO
Cidra
Pedro Rivera, M.D. (P)
PO Box 1518Cidra 00639
(Retired)
Santurce
Pedro Zayas, M.D. (D/C)
PO Box 14275
B.O. Obrero Station
Santurce
AC,BA,CT,FP,HGL,NT
SPAIN
Malaga
Henning Munksnaes, M.D. (P)
Medina Sidonia 192
Urb. Torre Nueva
Mijas Costa/Malaga
CT,DD,GYN,NT,P
SWITZERLAND
Geneva
Robert Tissot, M.D. (P)
168 Route de Malagnou
1224 Geneva
AU,NT,OSM,PM,PMR
Montreux
Claude Rossel, M.D., Ph.D. 
(P)
Clinique Bon Port
1820 Montreux
CT,NT,PM
Netstal (Glarus)
Walter Blumer, M.D. (P)
8754 Netstal
(Glarus bei Zurich)CT
(Honorary Life Member)
TAIWAN (R.O.C.) Taipei
Paul Lin, M.D. (P)
5 Lane 85 Sung Chiang Road
Taipei
CT,NT,PM
Yeh-Sung Lin, M.D. (P)
154 Sec. 1 Chien Kuo N. Road
Taipei
AN,CD,DD,DIA,END
WEST INDIES
Jamaica
H. Marco Brown, M.D. (D/C)
6 Corner Lane
Montego Bay, Jamaica
CT,NT,PMNotes
Chapter 1
The Painkiller With a Problem
1. Olver, I.N. ; J. Aisner; A. Hament; L. Buchanan; J.F. Bishop; and R.S. Kaplan. “A prospective study of topical dimethyl sulfoxide for treating anthracycline
extravasation.” 
Journal of Clinical Oncology
 (Nov. 1988); 6(11):1732–1735. 2. Babenko, V.N. “Treatment of patients with generalized periodontitis with a
suspension of indomethacin in a dimexide solution.” 
Stomatologiia
 (Mar./Apr. 1987); 66(2):26–28. 3. Goranov, K.; V. Zarankova; M. Velceva; and S. Dermend: zieva. “Clinical
results from the treatment of a hemorrhagic form of periodontosis with a
complex herb extract and 15 percent DMSO.” 
Stomatologiia
 (Nov./Dec. 1983); 65(6):25–30. Chapter 2
DMSO’s Controversial History
1. “DMSO Documents Sought,” 
NHF Public Scrutiny. Vol. XXVII, No. 27,
January, 1981, p. 29. 2. Szmant, H. Harry. “Physical properties of dimethyl sulfoxide and its function in
biological systems,” 
Biological Actions of Dimethyl Sulfoxide
, Stanley W.
Jacob and Robert Herschler (eds. ), New York: Annals of the New York
Academy of Sciences, Vol. 243, January 27, 1975, pp. 20–23. 3. Tackett, Michael. “Arthritis victims warned on solvent,” 
Chicago Tribune
,
November 16, 1980, p. 1. 4. Dewitt, Karen. “Drug DMSO studied as unauthorized use rises,” 
The New York
Times
, July 31, 1980, p. A11. 5. Sweeney, Thomas F. “Medicinal uses of marijuana get conflicting reviews,”
The Advocate
, January 28, 1981, p.2. 6. “Former Gov. Wallace travels to Oregon for special treatment,” 
The Advocate
,
June 30, 1980, p.3. Chapter 3
The Therapeutic Principle of DMSO1. Schlafer, H.L. and W. Schaffernicht. Angew. Chem
, 72:618, 1960. 2. Ranky, 
W.O. and D.C. Nelson. Organic Sulfur Compounds
 (N. Kharasch, ed. ),
Vol. 1, Pergamon, New York, 1961, p. 170. 3. MacGregory, W.S. Ann. N.Y. Acad. Sci. , 141:3, 1967. 4. Martin, D.; A. Weise; and H.J. Niclas. Angew. Chem
, 79:340, 1967. 5. Thomas, R.; C.B. Schoemaker; and K. Eriks. Acta Cryst. , 21:12, 1966. 6. Parker, A.J. Advances in Organic Chemistry, Methods and Results
, (R.A.
Raphael, E.C. Taylor, and H. Wynberg, eds. ), Vol. 5, Wiley (Interscience),
New York, 1965, p. 1. 7. Lindberg, J.J.; J. Kenttamaa; and A. Nissema. Suomen Kemistilehti
, 34B:98,
1961. 8. Schlafer and Schaffernicht, op. cit. 9. Wiberg, K.B. Physical Organic Chemistry
, Wiley, New York, 1964, p. 136. 10. Martin, Weise, and Niclas, op. cit. 11. Pruckner, H.; Erdoel; and Kohle, 
Acta Shandia Med. , 16:188, 1963. 12. Lindberg, J.J. 
Finska Kemistsamfundets Medd. , 77:130, 1968. 13. Kauzmann, W. 
Advan. Protein Chem. , 14:1, 1959. 14. Klotz, I.M. Brookhaven Symp. Biol. , 13:25, 1961. 15. Tanford, C. 
J. Am. Chem. Soc. , 84:4240, 1962. 16. Typley, J.A. J. Phys. Chem. , 68:2002, 1964. 17. Kligman, H.M. 
J. Am. Med. Soc. , 193:11, 1965. 18. Muset, P. Puig, and J. Martin Esteve. Experientia
, 21:649, 1965. 19. Horita, A., and L.J. Weber. Life Sci. (Oxford), 3:1389, 1964. 20. Herskovits, T.T., and M. Laskowski, Jr. 
J. Biol. Chem., 237:2481, 1962. 21. Hamaguchi, K. 
J. Biochem
 (Tokyo), 56:441, 1964. 22. Szmant, H. Harry. “Physical properties of dimethyl sulfoxide and its function
in biological systems,” 
Biological Actions of Dimethyl Sulfoxide
, ed. by
Stanley W. Jacob and Robert Herschler. New York: New York Academy of
Sciences, 1975, pp. 20–23. 23. Barfeld, H., and T. Atoynatan. “N-acetylcysteine inactivates migration
inhibitory factory and delayed hypersensitivity reactions,” 
Nature New Bio. ,
231:157–159, 1971. 24. Barfeld, H., and T. Atoynatan. “Cytophilic nature of migration inhibitory
factor associated with delayed hypersensitivity,” 
Proc. Soc. Exp. Biol. Med. ,
139:497–501, 1969. 25. Tschope, M., cited in Raettig, H. “The potential of DMSO in experimental
immunology,” 
Dimethylsulfoxyl. , Internationales Symposium in Wien. G.Laudahn and K. Getrich, eds.:54. Saladruck, Berlin, West Germany, 1966. 26. Jacob, Stanley W. “Dimethyl sulfoxide, its basic pharmacology and usefulness
in the therapy of headache,” 
Headache
, 5:78–81, October 1965. 27. Hucker, H.B. J. Pharmacol. Exp. Ther. , 155:309, 1967. 28. Maibach, H.I., and R.J. Feldman. Ann. N.Y. Acad. Sci. , 141:423, 1967. 29. Stoughton, R.B. Arch. Derm. , 91:657, 1965. 30. Stoughton, 
R.B. Toxic. Appl. Pharmacol. , 7:1, 1965. 31. Brink, J.J., and D.G. Stein. Science
, 158:1479, 1967. 32. Formanek, and W. Kovak. “Die wirkung von DMSO auf experimentell
erzeugte rattenpfotenodeme,” 
DMSO Symposium
, 1966, Saladruck, Berlin,
1966, p. 18. 33. Gorog, P., and I.B. Kovacs. Curr. Ther. Resp. , 10:486, 1968. 34. Weisman, G. 
Ann. N.Y. Acad. Sci. , 141:326, 1967. 35. Ibid. 36. Swanson, B.N. “Medical use of dimethyl sulfoxide (DMSO),” 
Reviews in
Clinical and Basic Pharmacology
 (Jan–June 1985), 5 (1–2):1–33. 37. Walker, Morton. Chelation Therapy. Stamford, Conn.: Freelance
Communications, 1980. 38. Walker,Morton. The Chelation Answer. New York: M. Evans & Co., 1982
Chapter 4
General Medical Uses for DMSO
1. Physicians’ Desk Reference
, Oradell, N.J.: Medical Economics Company,
1980. 2. “Doctor Claims DMSO Saved 11,” 
Ocala Star-Banner
, January 11, 1981, p.
10A. 3. Edelson, E. “DMSO,” 
Daily News
, June 9, 1980, p. 35. 4. Ashwood-Smith, M.H. “The radioactive action of dimethyl sulphoxide and
various other sulphoxides,” 
Intern J. Radiation Biol. 3:41, 1961. 5. Ashwood-Smith, M.H. “Radioprotective and cyroprotective properties of
dimethyl sulfoxide in cellular systems,” 
Ann. N.Y. Acad. Sci. , 141:45, 1967. 6. Hagemann, R.F., and J.C. Schaer, “The mechanism of modification of radiation
effect by dimethyl sulfoxide,” 
Experientia
, 27:319, 1971. 7. Grozdov, S.P. “Mechanism of the biological action and radiation-protective
effect of DMSO,” 
Radiobiologiya
, 11:522, 1971. 8. Lappenbusch, W.L. “On the mechanism of radioprotective action of dimethylsulfoxide,” 
Radiation Res. , 46:279, 1971. 9. Bridges, B. A. “The chemical protection of 
Pseudomonas
 species against
ionizing radiation,” 
Radiation Res. , 17:801, 1962. 10. Vos, O.; M.C.A. Kaalen; and L. Burdke. “Radiation protection by a number of
substances preventing freezing damage. I. Protection of mammalian cells 
in
vitro
,” 
Intern J. Radiation Biol. , 9:33, 1965. 11. Noel, J.F., and E.A. Wright. “In vitro
 radioprotection of mouse tail bones by
dimethyl sulphoxide, glycerol and anoxia,” 
Intern. J. Radiation Biol. , 18:301,
1970. 12. Dod, J.L., and J. Shewell. “Local protection against x-irradiation by
dimethylsulphoxide,” 
Brit. J. Radio. , 41:950, 1968. 13. Zharinov, G.M. ; S.F. Vershinina; and O.I. Drankova. “Prevention of radiation
damage to the bladder and rectum using local application of dimethyl
sulfoxide.” 
Meditsinskaia Radiologiia
, 30(3):16–18, March 1985. 14. Lovelock, J.E., and M.W.H. Bishop. “Prevention of freezing damage to living
cells by dimethyl sulphoxide,” 
Nature
, 183:1394, 1959. 15. De la 
Torre, J.C.; J. Meredith; and M.G. Netsky. “Cerebral air embolism in
the dog,” 
Arch. Neurol. , 6:307–316, 1962. 16. De la Torre, J.C.; H.M. Kawanga; D.W. Rowed; C.M. Johnson; K. Kajihara;
D. Goode; and S. Mullan. “Dimethyl sulfoxide in central nervous system
trauma,” 
Ann. N.Y. Acad. Sci. , 243:362–389, 1975. 17. Gabourie, J.; J.W. Becker; B. Bateman; M. Dunn; and S. Jacob. “Oral
dimethyl sulfoxide in mental retardation,” 
Ann. N.Y. Acad. Sci. , 245:449–459,
1975. 18. Aspillaga, M.J.; G. Morzon; I. Avendano; M. Sanchez; and L. Capdeville. “Dimethyl sulfoxide therapy in severe retardation in mongoloid children,” 
Ann. N.Y. Acad. Sci. , 241:423–431, 1975. 19. Engel, M.F. Ann. N.Y. Acad. Sci. , 141:638, 1967. 20. Fil’iulia. “Use of dimexide for the local treatment of surface burns,”
Klinicheskaia Khirurgiia
, (3):38–40, March 1985. 21. Jacob, S.W. Current Ther. Res. , 6:134, 1964. 22. Tsuchiva, T. 
Bull. Chem. Soc. , Japan 57:285, 1962. 23. Gabourie, Becker, Bateman, Dunn, and Jacob, op. cit. 24. Shelest, L.I. ; B.M. Brusilovski; B.V. Radionov; and V.S. Kuts. “Prospects of
using dimexide with antibiotic therapy.” 
Problemy Tuberkuleza
, (3):58–63,
1986. 25. Sebert, F.B. Ann. N.Y. Acad. Sci. , 243:175, 1967.26. More, R.C. ; J.M. Kabo; F.J. Dorey; R.A. Meals. “The effects of dimethyl
sulfoxide on post-traumatic limb swelling and joint stiffness,” 
Clinical
Orthopaedics and Related Research
, 233:304–310, August 1988. 27. Garrido, J.C., and R.E. Lagos. “Dimethyl sulfoxide therapy as toxicity-
reducing agent and potentiator of cyclophosphamide in the treatment of
different types of cancer,” 
Ann. N.Y. Acad. Sci. , 245:412–420, 1975. 28. Friend, C., and W. Scher. “Stimulation by dimethyl sulfoxide of erythroid
differentiation and hemoglobin synthesis in murine virus-induced leukemic
cells,” 
Ann. N.Y. Acad. Sci. , 243:155–163, 1975. 29. Spremulli, E.N., and D.L. Dexter. “Polar solvents: a novel class of
antineoplastic agents,” 
Journal of Clinical Oncology
, 2(3):227–241, March
1984. 30. Ostrow, S.S.; M.E. Klein; N.R. Bachur; M. Colvin; and P.H. Wiernik. “Cyclophosphamide and dimethylsulfoxide in the treatment of squamous
carcinoma of the lung. Therapeutic efficacy, toxicity, and pharmacokinetics,”
Cancer Chemotherapy & Pharmacology
, 6(2):117–120, 1981. 31. Egorin, M.J.; R.S. Kaplan; M. Saleman; J. Aisner; M. Colvin; P.H. Wiernik;
and N.R. Bachur. Cyclophosphamide plasma and cerebrospinal fluid kinetics
with and without dimethyl sulfoxide,” 
Clinical Pharmacology & Therapeutics
,
32(1):122–128, July 1982. 32. Kojima, K.; H. Hasegawa; T. Fujishiro; T. Yanai; S. Murai; N. Funahashi; M.
Mizuno; T. Ogawa; and S. Kawashima. “Successful treatments of plasma
exchange, hemodialysis, immunosuppressive agents and dimethylsulfoxide 
in a
case of myeloma kidney,” 
Nippon Jinzo Gakkai Shi
, 29(1):115–121, January
1987. 33. Volden, G.; E. Thorud; and O.H. Iversen. “Inhibition of methylcholanthrene-
induced skin carcinogenesis in hairless mice by the membrane-labilizing agent
DMSO,” 
British Journal of Dermatology
, 109 Suppl. 25:133–136, July 1983. 34. Jacob, S.W. “Dimethyl sulfoxide, its basic pharmacology and usefulness in
therapy of headache,” 
Headache
, 5:78–81, October 1965. 35. Burton, W.J. ; P.W. Gould; M.W. Hursthouse; P.J. Sears; D.A. Larnder; H.C.
Stringer; and B.C. Turnbull. “A multicentre trial of Zostrum (5 percent
idoxuridine in dimethyl sulphoxide) in herpes zoster,” 
New Zealand Medical
Journal
, 94(696):384–386, November 1981. 36. Sehtman, L. “Dimethyl sulfoxide therapy in various dermatological disorders,”
Ann. N.Y. Acad. Sci. , 245:395–402, 1975. 37. Miranda-Tirado, R. “Dimethyl sulfoxide therapy in chronic skin ulcers,” 
Ann.N.Y. Acad. Sci. , 241:408–411, 1975. 38. Lishner, M.; R. Lang; I. Kedar; and M. Ravid. “Treatment of diabetic
perforating ulcers (mal perforant) with local dimethylsulfoxide,” 
Journal of the
American Geriatrics Society
, 33(1):41–43, January 1985. 39. Ludwig, C.U. ; H.R. Stoll; R. Obrist; and J.P. Obrecht. “Prevention of
cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha
tocopherol,” 
European Journal of Cancer & Clinical Oncology
, 23(3):327–
329, March 1987. 40. Gordon, D.M. Ann. N.Y. Acad. Sci. , 141:551, 1967. 41. Hill, R.V. “Dimethyl sulfoxide in the treatment of retinal disease,” 
Ann. N.Y.
Acad. Sci. , 245:485–493, 1975. 42. Venegas, H. “Dimethyl sulfoxide therapy in sterility due to tubal obstruction,”
Ann. N.Y. Acad. Sci. , 245:494–496, 1975. 43. Kryzywicki, J. 
J. Czas. Stomat. , 11:1007, 1969. 44. Varshavski, A.I., and T.A. Guberskaia, “Use of dimethyl sulfoxide in the
combined treatment of the exacerbation of chronic parenchymatous parotitis,”
Stomatologiia
, 67(6):12–14, November-December 1988. 45. Kolomiets, L.I. “Effectiveness of ectericide, dimethyl sulfoxide and oxacillin
in treating acute, odontogentic inflammatory jaw diseases,” 
Stomatologiia
,
60(4):33–35, 1981. 46. Scherbel, A.L. ; L.J. McCormack; and M.J. Poppo. “Alteration of collagen in
generalized scleroderma (progressive systemic sclerosi) after treatment with
dimethyl sulfoxide,” 
Cleveland Clinic Quarterly
, 32–47, 1965. Chapter 5
The Toxicity and Side Effects of DMSO
1. Leake, CD. Science
, 152:1646:9, 1966
2. Smith, E.R. ; Z. Hadidian; and M.M. Mason. Ann. N.Y. Acad. Sci. , 141:96, 1967. 3. Smith, E.R. ; Z. Hadidian; and M.M. Mason. J. Clin. Pharmacol
, September-
October 1968, pp.315–321. 4. Smith, Hadidian, and Brown, op. cit. 5. Brown, J.H. Ann. N.Y. Acad. Sci. , 141, 496, 1976. 6. John, 
H., and G. Laudahn. Ann. N.Y. Acad. Sci. , 141, 506, 1967. 7. Kligman, A.M. 
J. Amer. Med. Assoc. , 193, 796, 923, 1965. 8. Demos, C.H. ; G.L. Beckloff; M.N. Donin; and P.M. Oliver. Ann. N.Y. Acad. Sci. , 141, 517, 1967.9. Elfbaum, S.G., and K. Laden. J. Soc. Cosmetic Chemists
, 19, 841–847, 1968;
CA. 71, 11478d. 10. Uranuma, T., Igaku. Kenkyu
, 30:2235, 1960. 11. Block, L.H. Drug & Cosmetic Ind. , 95(3), 342–346, 1964. 12. Feinman, H.; M. Ben; and R. Levin. Pharmacol. , 6, 188, 1964. 13. Melville, K.I. ; B. Klingner; and H.E. Shister. Arch. Pharmacodyn. , 174(2),
277–293, 1968. 14. Peterson, C.G., and R.D. Robertson. Ann. N.Y. Acad. Sci. , 141, 273, 1967. 15. Anon., 
Munchener Med. Wschr. , 108, 21, 1966. 16. Caujolle, F.; D. Caujolle; S. Cros; M. Calvet; and Y. Tollon. Compt. Rend. ,
260(1), 327–330, 1965; C.A. 62, 13724c. 17. Ferm, J.H., and J. Embryol. Exp. Morph. , 16(1), 49–54, 1966. 18. David, N.A. Annual Review of Pharmacol. , 12, 353–373, 1972. 19. Ayre, J.E., and J. LeGuerrier. Ann. N.Y. Acad. Sci. , 141, 414, 1967. 20. Lohs, Von K.; W. Damerau; and T. Schramm. Arch. Fur
Geschwulstforschung
, 37(1), 1–3, 1971. 21. Hegre, A.M., and R.E. Smith. AMLC-TR-67–4 Aerospace Med. Lab. Lackland AFB Texas. 22. Kligman, A.M. 
J. Invest. Dermat. , 47, 375–392, 1966. 23. Sulzberger, M.B. ; T.A. Cortese, Jr.; L. Fishman; H.S. Wiley; and P.S. Peyakovich. Ann. N.Y. Acad. Sci. , 141,437,1967. 24. McDermot, H.L. ; A.J. Finkbeiner; and B. Zanette. Can. J. Physicol. and
Pharmacol. , 45, 475, 1967. 25. Williams, K.I.H. ; K.S. Whittmore; T.N. Mellin; and D.S. Layne. Science, 149,
203–204, 1965. 26. Hucker, H.B. ; J.K. Miller; A.B. Hochberg; R. Brobyn; F.H. Riordon; and B.
Calesnick. J. Pharmacol. Exp. Ther. , 155, 309–317, 1967. 27. Gerhards, E., and H. Gibian. Ann. N.Y. Acad. Sci. , 141, 65–76, 1967. 28. Borgstedt, H.H., and V. DiStefano. Toxicol. & Appl. Pharmacol. , 10, 523–
528, 1967. 29. DiStefano, V., and H. Borgstedt. Science
, 144(3622), 1137–1138, 1964; CA. 61, 4868c. 30. Bull. AT. Sci. , 25(1):8–14, January 1969. 31. Caldwell, A.D.S. ; P.G.T. Bye; and M.H. Briggs. Nature
, 215, 1168, 1967. 32. Brobyn, R. 
Medical Tribune
, October 3, 1968. 33. Jenkins, B.H. Invest. Ophthalmol. , 5(3), 329, 1966. 34. Jacob, S.W., and D.C. Wood. Current Therap. Res. , 9(4), 229–233, 1967.35. Hull, F.W. ; D.C. Wood; and R.D. Brobyn. Northwest Medicine
, 68(1), 39–41,
1969. 36. Gordon, D.M. Ann. N.Y. Acad. Sci. , 141, 392, 1967. 37. Gordon, D.M., and K.E. Kleberger. Arch. Ophthal. , 79, 423, 1968. 38. Kleberger, K.E., and D.M. Gordon. Forthschr. Med. , 85(5), 171–174, 1967;
CA. 67, 52318n. 39. Sanders, M. 
Ann. N.Y. Acad. Sci
, 141, 649, 1967. 40. Wood, D.C; F.S. Weber; and M.A. Palmquist. J. Pharmacol. Exp. Therap. ,
177(3), 520–527, 1971. 41. Ibid., 528–535, 1971. 42. Brobyn, 
R.D. “The human toxicology of dimethyl sulfoxide,” 
Ann. N.Y. Acad. Sci. , 243:497–506, 1975. 43. Wood, D.C; D. Sweet; J. Van Dolah; J.C. Smith II; and I. Contaxis. Ann. N.Y.
Acad. Sci. , 141, 346–380, 1967; C.A. 67, 460h. 44. Mueller, F.O. ; P. O’Neill; and P.D. Trevor-Roper. Brit. J. Ophthal. , 51, 227,
1967. 45. Ibid., 13–30. 46. Kleberger, K.E. Graefes Arch. Klin. Exp. Ophthal. , 173, 269–281, 1967. 47. Rubin, L.F., and K.C. Barnett. Ann. N.Y. Acad. Sci. , 141, 333, 1967. 48. Barnett, K.C., and P.R.B. Noel. Nature
, 214, 1115–1116, 1967. 49. Kleberger and Gordon. Forthsch. Med. , 85(5), 171–174, 1967; C.A. 67,
52318n. 50. Smith, E.R. ; M.M. Mason; and E.E. Epstein. Ann. N.Y. Acad. Sci. , 141, 386,
1967. 51. Kleberger. Ann. N.Y. Acad. Sci. , 141, 381, 1967. 52. Kleberger. Graefes Arch. Klin. Exp. Ophthal. , 173, 269–281, 1967. 53. Ibid. 54. Ibid. 55. Wood, D.C; D. Sweet; J. Van Dolah; J.C. Smith II; and J. Contaxis. Ann. N.Y.
Acad. Sci. , 141, 346–380, 1967, C.A. 67, 460h. 56. Wood, D.C. 
Science
, 155, 404, 1967. 57. Rubin, L.F., and P.A. Mattis. Science
, 153, 83–84, 1966. 58. Caldwell, A.D.S. ; P.G.T. Bye; and M.H. Briggs. Nature
, 215, 1168, 1967. 59. Vogin, E.E. ; S. Carson; G. Cannon; C.R. Linegar; and L.F. Rubin. Toxicol. and
Appl. Pharmacol. , 16, 606–612, 1970. 60. Smith, E.R; M.M. Mason; and E.E. Epstein. J. Pharmacol. Exp. Ther. , 170–
172, 1969; C.A. 72, 30143c.61. Gordon, D.M., and K.E. Kleberger, 
Arch. Ophthal. , 79, 423, 1968. Chapter 6
The Potent Potion for Sports Injuries
1. Lang, J. “Potent potion for bum arm; Denehy ready now,” 
The Sporting News
,
March 13, 1971. 2. Percy, E.C., and J.D. Carson. “The use of DMSO in tennis elbow and rotator
cuff tendonitis: a double-blind study,” 
Medicine and Science in Sports and
Exercise
, 13(4):215–219, 1981. 3. “DMSO: New Hope for Arthritis?” Select Committee on Aging, House of
Representatives, Ninety-Sixth Congress. Washington, D.C: U.S. Government
Printing Office, Comm. Pub. No. 96–232, March 24, 1980, p. 136. Chapter 7
Arthritis Therapy With DMSO and Diet
1. Morassi, P.; F. Massa; E. Mesensnel; D. Magris; and B. D’Angnolo. “Treatment of amyloidosis with dimethyl sulfoxide (DMSO),” 
Minerva
Medica
, 80(1):65–70, January 1989. 2. Akimova, T.F. ; T.M. Novoselova; and A.P. Aliab’eva. “Current methods of
treating acute gouty arthritis,” 
Terapevticheskii Arkhiv
, 53(7):127–129, 1981. 3. Yoshimitsu, K.; N. Koga; Y. Kitamura; K. Fukuda; E. Kittaka; N. Horino; N.
Sakura; T. Tanaka; Y. Nishi; T. Sakano; et al. “Favorable effect of dimethyl
sulfoxide on secondary amyloidosis in juvenile rheumatoid arthritis,” 
Pediatric
Pharmacology
, 4(3):177–181, 1984. 4. Murav’ev, I.V., and A.P. Aliab’eva. “Dimethyl sulfoxide in the treatment of
amyloidosis in rheumatoid arthritis (case report),” 
Terapevticheskii Arkhiv
,
(11):38–39, 1981. 5. Tareev, E.M.; O.M. Vinogradova; L.N. Kochube; and T.V. Chegaeva. “Approaches to the treatment of amyloidosis,” 
Urologiia I Nefrologiia
, 6:56–
63, November-December 1983. 6. Takahashi, A.; J. Matsumoto; S. Nishimura; N. Tanada; S. Imura; T. Isobe; and
T. Shimoyama. “Improvement of endoscopic and histologic findings of AA-
type gastrointestinal amyloidosis by treatment with dimethyl sulfoxide and
prednisolone,” 
Gastroenterologia Japonica
, 20(2):143–147, April 1985. Chapter 9Using DMSO in Head and Spinal Cord Injuries
1. De la Torre, J.C; J.W. Surgeon; P.K. Hill; and T. Khan. “DMSO in the
treatment of brain infection: basic considerations,” 
Arterial Air Embolism and
Acute Stroke
 (eds. J.M. Hallenbeck and L.J. Greenbaum), Undersea Medical
Society Report No. 11–15–77:138–161, 1977. 2. De la Torre, J.C., and P.K. Hill, “Ultrastructural studies on formation of edema
and its treatment following experimental brain infarction in monkeys,”
Dynamics of Brain Edema
 (eds. H. Pappius and W. Feindel), Berlin: Springer,
1976, pp. 306–314. 3. De la Torre, J.C., and J.W. Surgeon. “Dexamethasone and DMSO in
experimental transorbital cerebral infarction,” 
Stroke
, 7:577–583, 1976. 4. Deutsch, E. “Beeinflussung de blutgerinnung durch DMSO und kombinationen
mit heparin,” DMSO 
Symposium, Vienna
, Berlin: Saladruck, 1966, p. 144. 5. White, R.P. “Prostaglandin F2 Alpha and experimental cerebral vasospasm in
dogs,” 
Pharmacologist
, 13:292, 1972. 6. Weeks, J.R. “The prostaglandins: biologically active lipids with implications in
circulatory physiology,” 
Circ. Res. , 24:1223–1229, 1969. 7. LaHann, T.R., and A. Horita. “Effects of dimethyl sulfoxide (DMSO) on
prostaglandin synthetase,” 
Proc. West. Pharmacol. Soc. , 18:81–82, 1975. 8. Coceani, F. “Prostaglandins and the central nervous system,” 
Arch. Intern. Med. , 133:119–129, 1974. 9. Bergstrom, S. “Prostaglandins: members of a new hormonal system,” 
Science
,
157:382–391, 1967. 10. Dujovny, M.; P.J. Barrionuevo; R.K. Laha; S. De Castro; and J.C. Maroon. “Experimental middle cerebral artery microsurgical embolectomy,” 
Surg. Forum
, 37:495–596, 1976. 11. Dujovny, M.; P.J. Barrionuevo; R.D. Laha; G. Solis; J. Maroon; and R.H.
Hellstrom. “The role of DMSO and methylprednisolone in canine middle
cerebral artery microsurgical embolectomy,” 
Stroke
, 8:6–7, 1977. 12. De la 
Torre, Surgeon, Hill, and Kahn, op. cit. 13. Kajihara, K.; H. Kawanaga; J.C. de la Torre; and S. Mullan. “Dimethyl
sulfoxide in the treatment of experimental acute spinal cord injury,” 
Surgical
Neurology
, 1:16–22, 1973. 14. De la Torre, J.C.; D.W. Rowed; H.M. Kawanaga; and S. Mullan. “Dimethyl
sulfoxide in the treatment of experimental brain compression,” J. 
Neurosurg. ,
38:345–354, March 1973.15. Schmeck, H.M., Jr. “Scientists seek to test controversial solvent on disease of
muscles,” 
The New York Times
, January 15, 1981, p. A21. 16. Marshall, L.F.; P.E. Camp; and S.A. Bowers. “Dimethyl sulfoxide for the
treatment of intracranial hypertension: a preliminary trial,” 
Neurosurgery
,
14(6):659–663, June 1984. 17. Zingerman, L.I. “Dimexide (dimethyl sulfoxide) in the treatment of multiple
sclerosis,” 
Zhurnal Neuropatologii I Psikhiatrii Imeni S. S. Korsakova
,
84(9):1330–1333, 1984. Chapter 10
DMSO Therapy for Mental Disabilities
1. Gesell, A. 
Developmental Diagnosis
, New York: Paul Hoeber, 1946. 2. Aspillaga, M.J.; C. Morizon; I. Avendano; M. Sanchez; and L. Capdeville. “Dimethyl sulfoxide therapy in severe retardation in mongoloid children,” 
Ann. N.Y. Acad. Sci. , 243:421–431, 1975. 3. Giller, A. and M.E.M. de Bernadou. “Dimethyl sulfoxide therapy in
nonmongoloid infantile oligophrenia,” Ann. N.Y. Acad. Sci. , 243:432–448,
1975. 4. Givovich, L.; M. Colombo; and Y. Lacassie. “Present treatment of Down’s
syndrome,” 
Revista Chilena De Pediatria. , 53(5)496–502, September-October,
1982. 5. Hoffer, A. and M. Walker. Smart Nutrients. Garden City Park, N.Y.: Avery
Publishing Group, 1993. Chapter 11
The DMSO-Cancer Connection
1. Tucker, E.J. and A. Carrizo. “Hematoxylon dissolved in dimethyl sulfoxide
used in recurrent neoplasms,” International Surgery, 49:516–527, June 1968. 2. Volden, G.; E. Thorud; and O.H. Iversen. “Inhibition of methylcholanthrene-
induced skin carcinogenesis in hairless mice by membrane-labilizing agent
DMSO,” 
British Journal of Dermatology
, 109 Suppl. 25: 133–136, July 1983. 3. Unpublished treatise by Thomas D. Rogers, Northwestern State University,
“Light and electron microscope studies of the chemotherapeutic effect of a
combination of dimethyl sulfoxide and hematoxylon on a transplantable
lymphosarcoma,” January 1979.Chapter 12
Infectious Diseases Respond to DMSO
1. “Antiviral drug, DMSO teamed 
against shingles,” 
Drug Topics
, February 15,
1971. 2. Zuniga, A.; R. Burdach; and S. Rubio. “Dimethyl sulfoxide therapy in
bronchiolitis,” 
Ann. N.Y. Acad. Sci. , 243:460–467. 3. Zuniga, A. “Dimethyl sulfoxide therapy in subjective tinnitus of unknown
origin,” 
Ann. N.Y. Acad. Sci. , 243:468–474. 4. Zimmerman, S.J. ; M.B. Maude; and M. Moldawer. “Freezing and storage of
human semen in 50 healthy medical students. A comparative study of glycerol
and dimethylsulfoxide as a preservative,” 
Fertility Sterility
, 15:505, 1964. 5. Smith, G.C. “Observations in treating Cutaneous Larva Migrans,” 
J.S. Carolina
Med. Assoc. , 62:265, 1966. 6. Katz, R. and R.W. Hood. “Topical thiabendazole for creeping eruption,” 
Arch. Dermatol. , 94:643, 1966. 7. Bogoiavlenski, I.F. ; I.O. Zaks; and S.I. Ivanov. “Dimexide therapy of septic
complications in critical status,” 
Ruesteziologiia I Reanimatologiia
, (4):38–40,
July-August 1984. 8. Scheinberg, M.A. ; J.C. Permambuco; and M.D. Benson. “DMSO and
colchicine therapy in amyloid disease,” 
Annals of the Rheumatic Diseases
,
43(3): 421–423, June 1984. 9. Pravata, G.; G. Pinto; M. Bosco; G. Noto; and M. Arico. “Unusual localization
of lichen amyloidosus. Topical treatment with dimethyl sulfoxide,” 
Acta
Dermato-Venereologia
, 69(3):259–260, 1989. 10. Fil, I.; A.D. Zhenchenko; A. Ukhov; and N.P. Popovich. “Prevention of
suppurative complications of surgical wounds at a polyclinic,” 
Klinicheskaia
Khirurgiia
, (1):58–59, 1988. 11. Sachek, M.G. ; D.K. Novikov; and V.P. Bulakin. “Basis of immunocorrective
therapy among patients with chronic osteomyelitis,” 
Vestnik Khirurgii Imeni
I.I. Grekova
, 136(3):51–53, March 1986. 12. Glozman, V.N. “Clinico-diagnostic aspects of the use of proteases and
dimexide in ochiepididymitis,” 
Urologia I Nefrologia
, (6):50–52, 1986. Chapter 13
Misreporting of DMSO for Scleroderma and Interstitial Cystitis1. Becker, D.P. ; H.F. Young; F.E. Nulsen; et al. “Physiological effects of
dimethyl sulfoxide on peripheral nerves: possible role in pain relief,” 
Exp. Neurol
, 24:272–276, 1969. 2. Engel, M.F. “Dimethyl sulfoxide in the treatment of scleroderma,” 
Southern
Medical Journal
, 65:71–73, January 1972. 3. Heise, H., and P. Skierlo. “Circumscribed scleroderma—local treatment with
dexamethasone-dimethyl sulfoxide preparation,” 
Dermatologische
Monatsschrift
, 172(1):29–32, 1986. 4. Sergeev, V.P. “Mechanism of the therapeutic efficacy of dimexide in patients
with circumscribed scleroderma,” 
Vestnik Dermatologii I Venerologii
, (7):64–
66, July 1983. 5. Scherbel, A.L. “The effect of percutaneous 
dimethyl sulfoxide on cutaneous
manifestations of systemic sclerosis,” 
Ann. N.Y. Acad. Sci. , 411:120–130,
1983. 6. Williams, H.J. ; D.E. Furst; S.L. Dahl; V.D. Steen; C. Marks; E.J. Alpert; A.M.
Henderson; C.O. Samuelson, Jr.; J.N. Dreyfus; A. Weinstein; et al. “Double-
blind, multicenter controlled trial comparing topical dimethyl sulfoxide and
normal saline for treatment of hand ulcers in patients with systemic sclerosis,”
Arthritis and Rheumatism
, 28(3):308–314, March 1985. 7. Perez-Marrero, R.; L.E. Emerson; and J.T. Feltis. “A controlled study of
dimethyl sulfoxide in interstitial cystitis,” 
Journal of Urology
, 140(1):36–39,
July 1988. 8. Conejero Sugranes, J.; G. Llamazares Cach; J. Avila Padilla; F. Sarrias Lorenz;
L. Sabin; and P. Zamora. “Treatment of the complex irritative bladder
syndrome with dimethyl sulfoxide,” 
Actas Urologicas Espanolas
, 9(6):527–
530, November-December 1985. 9. Okamura, K.; M. Mizunaga; S. Arima; S. Tokunaka; F. Inada; T. Takamura;
and S. Yachiku. “The use of dimethyl sulfoxide in the treatment of intractable
urinary frequency,” 
Hinyokika Kiyo-Acta Urologica Japonica
, 31(4):627–631,
April 1985. 10. Tereszkiewicz, J. and T. Spruch. “Urethral syndrome in women and its
treatment with dimethyl sulfoxide,” 
Ginekologia Polska
, 58(7):473–477, 1987. 11. Osanai, H.; K. Yamauchi; M. Morikawa; Y. Nakata; S. Tokunaka; F. Inada;
and S. Yachiku. “A case of bladder amyloidosis,” 
Hinyokika Kiyo-Acta
Urologica Japonica
, 32(2):261–267, February 1986. Appendix I1. Kito, S.; E. Itoga; M. Inokawa; M. Hironaka; T. Kishida; and T. Shinoda. “Studies on biological actions of dimethyl sulfoxide in familial amyloidosis,”
Ann. N.Y. Acad. Sci. , 411:52–66, 1983. 2. Sabatelli, M.; C. Casali; C. Scoppetta; A. Frustaci; and P. Tonali. “Familial
amyloid polyneuropathy. Description of two cases treated with dimethyl
sulfoxide,” 
Rivista Di Neurobiologia
, 30(2–3):261–267, April-September
1984. 3. Monfrecola, G.; R. Iandoli; G. Bruno; and D. Martellotta. “Lichen amyloidosus:
a new therapeutic approach,” 
Acta Dermato-Venereologica
, 65(5):453–455,
1985. 4. Hsieh, S.D. ; R. Yamamoto; K. Saito; Y. Iwamoto; T. Kuzuya; S. Ohba; S.
Kobori; and K. Saito. “Amyloidosis presented with whitening and loss of hair
which improved after dimethyl sulfoxide treatment,” 
Japanese Journal of
Medicine
, 26(3):393–395, August 1987. 5. Wang, W.J. ; C.S. Lin; and C.K. Wong. “Response of systemic amyloidosis to
dimethyl sulfoxide,” 
Journal of the American Academy of Dermatology
, 15(2
part 2):402–405, August 1986. 6. Ravid, M.; J. Shapira; R. Lang; and I. Kedar. “Prolonged dimethyl sulphoxide
treatment in 13 patients with systemic amyloidosis,” 
Annals of the Rheumatic
Diseases
, 41(6):587–592, 1982. 7. Gruys, E.; R.J. Sijens; and W.J. Biewenga. “Dubious effect of dimethyl
sulphoxide therapy on amyloid deposits and amyloidosis,” 
Veterinary
Research Communications
, 5(1) 21–32, September 1981. 8. Yachiku, S. “Experience with dimethyl sulfoxide treatment for primary
localized amyloidosis of the bladder,” 
Journal of Urology
, 135(3):580–582,
March 1986. 9. Dai, K.Y. ; J.C. Montet; X.M. Zhao; J. Amic; and R. Choux. “Dissolving agents
of human mixed cholesterol stones,” 
Gastroenterologie Clinique Et
Biologique
, 12(4):312–319, April 1988. 10. Asakawa, S.; H. Igimi; and H. Shimura. “A new direct solubilizer for
bilirubinate calcium stones,” 
Nippon Geka Gakkai Zasshi–Journal of the
Japanese Surgical Society
, 84(10):1072–1083, October 1983. 11. Sotolong, J.R., Jr.; F. Swerdlow; H.I. Schiff; and H.E. Schapira. “Successful
treatment of lupus erythematosus cystitis with DMSO,” 
Urology
, 23(2):125–
127, February 1984. 12. Kolomiets, L.I. “Effectiveness of ectericide, dimethyl sulfoxide, and oxacillin
in treating acute, odontogenic inflammatory jaw diseases,” 
Stomatologiia
,60(4):33–35, 1981. 13. Kavli, G.; K. Midelfart; G. Volden; and H. Krokan. “Photochemical reactions
of Heracleum Iaciniatum. Influence of dimethyl sulphoxide and
corticosteroids,” 
British Journal of Dermatology
, 109 Suppl 25:137–140, July
1983.Bibliography
Albert, H.M., “Effects of DMSO on the Healing of Wounds,” 
Presse Med. , 75, 20,
1967. Annals New York Academy of Sciences
, “Biological Actions of Dimethyl
Sulfoxide (DMSO),” Vol. 141, 1–671:1967. Arno, I.C., Wapner, P.M., and Brownstein, I.E., “Experiences With DMSO in
Relief of Postpartum Episiotomy Pain,” 
Annals New York Academy of Sciences
,
141, 403, 1967. Ayre, J.E., and Leguerrier, J., “Some (Regressive) Effects of DMSO
Dexamethasone Upon Cervical Cells in Cervical Dysplasia and Carcinoma in
Situ,” 
Annals New York Academy of Sciences
, 141, 414, 1967. Bernath, Z., Chacon, E., Bennett, N., and Riveros, A., “Experiencia Clinica en
Tratamiento del Sindrome Asmatico con una Combinacion de DMSO 1.3
Dimetixantina-Etilendiamina, Clorfeniramina y un Anti-Inflamatorio,” 
Rev. Medica
de Valparaiso. Dic. 1969. Berrios De La Luz, R., Pfister, H., Junemann, C., and Perales, L., “Terapia Para
Artrosis y Artritis con Artrotin un Preparado a Base de DMSO, Gama-
Cetofenibutazona y Dexametazona,” 
Boletin de la Soc. Chilena de Reumatologia,
Vol. IX, No. 1
, Abril 1971; Santiago, Chile. Bien, K., “Particular Properties of Dimethyl Sulfoxide (DMSO) in the Light of
Current Clinical Investigations,” 
Polski Tygod. Lekar. , 21, 688, 1966. Blum, E.O., “Erfahrungen mit Dolicur bei Chirurgischen Erkrankungen Unter
Besonderer Beruecksichtigung der Vertraeglichkeit,” 
DMSO Symposium
,
Herausgegeben von Priv.—Doz. Laudahn, G., Saladruck, Berlin, 1965, p. 102. Bottomly, D.R., Shimazaki, Y., and Bachman, D.M., “Controlled Study of
Dimethyl Sulfoxide Effects in Patients with Connective Tissue Diseases,”
Arthritis Rheumato. , 7, 294, 1964.Brown, J.H., “Treatment of Aerotits and Aerosinusitis With Topical DMSO,”
Aerospace Medicine
, 38, 629, 1967. Brucher, E., Munizaga, G., and Torres, P., “Accion Terapeutica de Merinex en
Diversas Afecciones Organica-Cerebrales,” 
Rev. Hosp. Psiquiatrico, Vol. 1
,
Enero 1970, Santiago, Chile. Cerimele, D., and Pisanu, G., “Rapporto fra Aziones dei Corisonici ed Aggiunta
Dimetilsulfossido (Importanza delia Concentrazione),” 
Redaziones il. , 21, VII,
1966. Chan, J.C., and Gadebusch, H.H., “Virucidal Properties of Dimethyl Sulfoxide,”
Applied Microbiology
, 16, 1625, 1968. Cors, J., “Anti-Inflammatory Effects of DMSO,” 
Bull Trav. Soc. Pharm. Lyon
, 9,
213, 1965. Day, P.L., “Final Evaluation of One Thousand Cases Treated in Orthopaedic
Practice With DMSO,” 
DMSO Symposium
, Vienna. Herausgageben von Priv.—
Doz. Daudhan, G., and Gertich, K. (eds. ), 1966, p. 107. Escobar, E., and Cornejo, J., “Una Neuva Quimioterapia Antiblastica, Potenciada
e Hipotoxica, Ciclofosfamido-Sulfoxidanta (DMSO),” 
Rev. de Hosp. San Fco. de
Borja
, Vol. 6 No. 3, Septbre, 1971, Stgo., Chile. Finney, J.W., and Urschel, H. and Co., “Protection of the Ischemic Heart With
DMSO Alone or DMSO With Hydrogen Peroxide,” 
Annals New York Academy of
Sciences
, Vol. 141, 1, 231–241, 1967. Frommhold, W., and Bublitz, G., “Untersuchungen uber Unterhautifibrosen nach
Telekobalttherapie und ihre Behandlungsmoeglichkeiten mit Dimethylsulfoxyd
(DMSO),” 
Strahlentherapie
, 133, 529, 1967. Gerhards, E., “Uber Stoffwechsel und Stoffwechselwirkungen von
Dimethylsulfoxyd,” 
DMSO Symposium
, 1965, Laudahn, G. (ed. ), Saladruck,
Berlin, 1965, p. 18. Grismali, J., and Varela, L., “Uso de Ipran en Neurologia,” 
Rev. Hosp. San Fco.De Borja
, Vol. 5, No. 4, Dic. 1970, Santiago, Chile. Grismali, J., and Varela, L., “Terapia con Merinex en Neurosis Depresiva 
de
Angustia e Histerica,” 
Rev. Hosp. San Fco. de Borja
, Vol. 5, No. 2, Junio 1970,
Santiago, Chile. Herschler, R.J., and Jacob, S.W., “DMSO-Therapy in Peripheral Vascular
Disease,” U.S. Patent Pending, 1964 (Patent royalties assigned to University of
Oregon Medical School). Herschler, R.J., and Jacob, S.W., “DMSO-Therapy in Burns,” U.S. Patent Pending,
1964 (Patent royalties assigned to University of Oregon Medical School). Herschler, R.J., and Jacob, S.W., “DMSO: A New Drug from Lignin,” 
TAPPI
48:43A–46A, 1965. Jacob, S.W., “Dimethyl Sulfoxide (DMSO), Its Basic Pharmacology and
Usefulness in the Therapy of Headache,” 
Headache
, 5:78–81, October, 1965. Jacob, S.W., “Dimethyl Sulfoxide (DMSO),” 
McGraw-Hill Yearbook of Science
and Technology
, 1966, McGraw-Hill Book Company
Jacob, S.W., “DMSO: Potential Usefulness in Physical Therapy,” 
Physical
Therapy
, 49:470, 1969. Jacob, S.W., “Dimethyl Sulfoxide (DMSO): Current Concepts in Toxicology,
Pharmacology, and Clinical Usefulness in Surgery,” 
American Surgeon
, 35:564,
1969. Jacob, S.W., Bischell, M., Eberlec, G., and Herschler, R.J., “The Influence of
Dimethyl Sulfoxide on the Transport of Insulin Across a Biologic Membrane,”
Federation Proceedings
 23:410, 1964. Jacob, S.W., Bischel, M., and Herschler, R.J., “Dimethyl Sulfoxide (DMSO): A
New Concept in Pharmacotherapy,” 
Current Therapeutic Research
 6: 134–135,
1964. Jacob, S.W., Bischel, M., and Herschler, R.J., “Dimethyl Sulfoxide (DMSO):Effects on the Permeability of Biologic Membranes (Preliminary Report),” 
Current
Therapeutic Research
 6:193–198, 1964. Jacob, S.W., Herschler, R.J., and Rosenbaum, E.E., “Dimethyl Sulfoxide (DMSO):
Laboratory and Clinical Evaluation,” 
Journal of the American Veterinary Medical
Association
, 147, 12:1350–1359, December 15, 1965. Jacob, S.W., and Rosenbaum, E.E., “The Toxicology of Dimethyl Sulfoxide
(DMSO),” 
Headache
, 6:127–135, October, 1966. Jacob, S.W., and Rosenbaum, E.E., “Dimethyl Sulfoxide (DMSO), An Evaluation
After Two Years of Clinical Experience,” 
DMSO Symposium
, 1966, Vienna, p.
83, Saladruck, Berlin, 1966. Jacob, S.W., and Wood, D.C., “Notes on Dimethyl Sulfoxide (DMSO),”
Symposium: Vienna, Austria, November 8–9, 1966. Current Therapeutic
Research
 9:229–233, 1967. Jacob, S.W., and Wood, D.C., “Summary of Dimethyl Sulfoxide Symposium,”
Arznei-For
 17: 1086, 1967. Jacob, S.W., and Wood, D.C., “Dimethyl Sulfoxide (DMSO) Toxicology,
Pharmacology and Clinical Experience,” 
Amer. Your. Surg. 114:414–427, 1967. Jacob, S.W., Wood, D.C., and Brown, J.H., “Therapeutic Potential of Dimethyl
Sulfoxide (DMSO),” 
Aerospace Medicine
, Aerospace Med. 40, 75, 1969. Kajihara, K., Kawanaga, H., de La Torre, J.C., and Mullan, Sean, “Dimethyl
Sulfoxide in the Treatment of Experimental Acute Spinal Cord Injury,” 
Surgical
Neurology
, 1973, Vol. 1 No. 1, pg. 16–22. Kaminsky, A., “Dimethyl Sulfoxide: Its Possibilities in Dermatology,” 
Rev. Assoc. Med. Arg. , 79, 556, 1965. Kamiya, S., Wakao, T., and Nishioka, K., “Studies on Improvement of Eye Drops. 3. Bacteriological Consideration of DMSO,” 
Rinsho Ganka
 (
Japanese Journal of
Clinical Opthalmology
), 20, 143, 1966.Kocsis, J.J., Harkaway, S., Vogel, W.H., Brink, J.J., and Stein, D.G., “Dimethyl
Sulfoxide Breakdown of Blood-Brain Barrier,” 
Science
, 160, 1471, 1968. Lau, H., Limberger, J., and Muller, H., “Treatment of Mastopathies With Dimethyl
Sulfoxide,” 
Deut. Med. Wochschr. , 93, 2102, 1968. MacCallum, F.O., and Juel-Jensen, B.E., “Herpes Simplex Virus Skin Infection in
Man Treated with Idoxuridine in Dimethyl Sulfoxide, Results of Double Blind
Controlled Trial,” 
Brit. Med. J.
, 2, 805, 1966. Matsumoto, J., “Clinical Trials of Dimethyl Sulfoxide in Rheumatoid Arthritis
Patients in Japan,” 
Annals New York Academy of Sciences
, 141, 560, 1967. Munizaga, G., “Decaimiento Psico-Organico y Consideraciones 
Terapeuticas,”
Rev. Hosp. San Fco. Borja
, Vol. 5, No. 3, Septbre. 1970. Santiago, Chile. Narula, P.N., and Jacob, S.W., “The Cryoprotective Effect of Dimethyl Sulfoxide
and Glycerol on Cell Cultures at Various Temperatures,” 
Cryobiology
 2:32, 1965. Narula, P.N., and Jacob, S.W., “The Cryoprotective Effect of Methyl Cellulose
(Methacel) With Dimethyl Sulfoxide and Glycerol on Cell Cultures,” 
Cryobiology
2:32, 1965. Nassar, C., “Experiencia Clinica con Merinex en Ninos con Deficit Mental y
Dificultades de Aprendizaje Basico,” 
Rev. Med. de Valparaiso
, Vol. XXII, Dic. 1969. Paul, M.M., “Comparison of DMSO and Conventional Methods of Therapy in the
Treatment of Soft Tissue Athletic Injuries,” 
DMSO Symposium
, Vienna, 1966,
Laudahn, G. (ed. ), Saladruck, Berlin, 1966, p. 101. Paulin, H.J., Murphy, J.B., and Larson, R.E., “Determination of Dimethyl
Sulfoxide in Plasma and Cerebrospinal Fluid by Gas-Liquid Chromatography,”
Anal. Chem. 38, 651, 1966. Penrod, D.S., Bacharach, B., and Templeton, J.Y., “III. Dimethyl Sulfoxide for
Incisional Pain After Thoracotomy: Preliminary Report,” 
Annals New York
Academy of Sciences
, 141, 493, 1967.Perce, H.L., “Dimethyl Sulfoxide (DMSO) the Wonder Drug,” 
Current Pediatry
,
13, 7, 1964. Perlman, F., and Wolfe, H.F., “Dimethyl-Sulfoxide as a Penetrant Carrier of
Allergens Through Intact Human,” 
J. Allergy
, 38, 299, 1966. Persky, L., and Stewart, B.H., “The Use of Dimethyl Sulfoxide in the Treatment of
Genitourinary Disorders,” 
Annals New York Academy of Sciences
, 141, 551, 1967. Rosenbaum, E.E., Herschler, R.J., and Jacob, S.W., “Dimethyl Sulfoxide (DMSO)
in Musculoskeletal Disorders,” 
JAMA
 192:309–313, 1965. Rosenbaum, E.E., and Jacob, S.W., “Dimethyl Sulfoxide (DMSO) in the Treatment
of Musculoskeletal Injuries and Inflammations, II. The Treatment of Rheumatoid
Arthritis, Degenerative Arthritis, and Gouty Arthritis, a Preliminary Report,”
Northwest Medicine
 63:227–229, 1964. Rosenbaum, E.E., and Jacob, S.W., “Dimethyl Sulfoxide (DMSO) in the 
Treatment
of Acute Musculoskeletal Injuries and Inflammations, I. Dimethyl Sulfoxide in
Acute Subdeltoid Bursitis,” 
Northwest Medicine
 63:167–168, 1964. Rosenbaum, E.E., and Jacob, S.W., “The Use of Dimethyl Sulfoxide (DMSO) for
the Treatment of Intractable Pain in Surgical Patients,” 
Surgery
 58:258–266, 1965. Sabah, D., “Tratamiento Combinado con Gamma-Cetofenibutazona,
Dexametasona y DMSO en Artritis Reumatoidea y Otras Colagenopatias,” Boletin
Soc. Chilena de Reumatologia, Vol. VII, No. 12, Septbre. 1970, Stgo., Chile. Solano-Aguilar, E., “Dimethyl Sulfoxide con Triamcinolona en Varias
Dermatosis,” 
Rev. Med. Costa Rica
, 33, 231, 1966. Steimberg, A., “Clinical Applications of Dimethyl Sulfoxide in Collagenous and
Musculoskeletal Diseases,” 
DMSO Symposium
, Vienna, 1966, Laudahn, G. (ed. ),
Saladruck, Berlin, 1966, p. 20. Steimberg, A., “The Employment of Dimethyl Sulfoxide as an Anti-Inflammatory
Agent and Steroid-Transporter in Diversified Clinical Diseases,” 
Annals New
York Academy of Sciences
, 141, 532, 1967.Stein, D.G., and Brink, J.J., “Prevention of Retrograde Amnesia by Injection of
Magnesium Pemoline,” 
Dimethylsulfoxide-Psychopharmacology
, 14, 240, 1969. Stelzer, J.M., Colaizzi, J.L., and Wurdack, P.J., “Influence of Dimethyl Sulfoxide
(DMSO) on Percutaneous Absorption of Salicylate Acid and Sodium Salcylate
From Ointments,” 
J. Pharm. Sci. , 57, 1732, 1968. Stewart, B.H., “Dimethyl Sulfoxide (DMSO) in the Treatment of Troublesome
Genitourinary Disorders: A Preliminary Report,” 
Cleveland Clinic Quarterly
, 33,
81, 1966. Stewart, B.H., Versky, L., and Kiser, W.S., “Use of Dimethyl Sulfoxide (DMSO)
in Treatment of Interstitial Cystitis,” 
J. Urol. 98, 671, 1967. Stewart, G., and Jacob, S.W., “Use of Dimethyl Sulfoxide (DMSO) in the
Treatment of Post Amputation Pain,” 
American Surgeon
 31:460–462, 1965. Stoughton, R.B., and Fritsh, W., “Influence of Dimethyl Sulfoxide (DMSO) on
Human Percutaneous Absorption,” 
Arch. Dermatol. , 90, 512, 1964. Stringer, H., and Engel, G.B., “Dimethyl Sulfoxide for Nail Infection,” 
Lancet
,
7441, 825, 1966. Tellex, A., “Experiencia Terapeutica con Ipran en Psiquiatria de la Edad
Avanzada,” 
Rev. Hospital Psiquiatrico
, Vol 1. No. 2, Junio 1970, Santiago, Chile. Torre de la, J.C., Rowed, D.W., Kawanaga, H.M., and Mullan, S., “Dimethyl
Sulfoxide in the Treatment of Experimental Brain Compression,” 
Journal of
Neurosurgery
, Volume 38, March 1973. Tucker, E.J., and Carrizo, A., “Hematoxylon Dissolved in Dimethylsulfoxide Used
in Recurrent Neoplasms,” 
Intern. Surg. , 49, 516, 1968. Venerando, A., “On Therapeutic Action of Dimethyl Sulphoxide (RE 421) in Sport
Trauma and in Osteoarticular Atlas Diseases,” 
Gaz. Intern. Med. Chir. , 70, 1605,
1965, in Italian. Vishwakarma, S.K., “Dimethyl Sulfoxide in Tympanoplasty. A PreliminaryReport,” 
Plastic Reconstructive Surgery
, 42, 15, 1968. Weitgasser, H., “Dermatological Investigations with Dimethylsulfoxide (DMSO),”
Z. 
Haut-Geschlechts Krankh. , 21, 749, 1967. Weitgasser, H., “Die Lokalbehandlung von Chronischen Paronychien mit Einer
Kombination von Triamcinolon-Acetonid und Dimetilsulfoxide,” Z. 
Haut-
Geschlechts Krankh. , 44, 27, 1969. Wodniansky, P., “Dupuytrem und Sklerodermie,” 
DMSO Symposium
, Vienna,
1966, Laudahn, G. (ed. ), Saladruck, Berlin, 1966, p. 158. Yeats, R.O., Preliminary Test Using DMSO as a Vehicle for Drugs in Leprosy,”
Annals New York Academy of Sciences
, 141, 668, 1967. Ziv-Silberman, G., “DMSO in the Treatment of Chronic Mastitis,” 
Veterinary
Record
, 81, 527, 1967. Zuckner, J., and Uddin, J., “Local Applications of Dimethyl Sulfoxide (DMSO)
and DMSO Combined With Trincinolone Acetonide in Rheumatoid Arthritis,”
Nature
, 1389, 55, 1965.Index
The page numbers in this index refer to the printed version of this book. To find
the corresponding locations in the text of this digital version, please use the
“search” function on your e-reader. Note that not all terms may be searchable. Adenocarcinoma, 177, 180, 182. See also
 Cancer, DMSO and. AIDS, DMSO and, 221
Aloe vera, for DMSO–treated skin, 46
American College of Advancement in Medicine, 34, 40, 68
American Home Products, 128
American Pharmaceutical Enterprises, 20
American Podiatry Association, 128
Annals of Rheumatic Diseases
, 221
Anthracycline, extravasation of, 4–5
Armour Pharmaceutical Company, 128
Arthritis, DMSO and, 106–124
amyloidosis, 42, 122, 123
anti-arthritis diet, 115–121
orthodox treatment of, 107, 108
role of sugar in, 115, 117–118
spondylitis, 83–84, 111
wrapping technique, 114–115, 131–132
See also
 Osteoarthritis; Rheumatoid arthritis. Arthritis Foundation and DMSO, 108–110
Aspillaga, Manuel, M.D., 168
Asthma, DMSO and, 69–70
Atherosclerosis, DMSO and, 46
Athlete’s foot. See
 Foot and leg problems, DMSO and. Avendano, Isabel, M.D., 168
Avery, Lorae, PhD, 2, 3
Back pain, DMSO and, 84–85
Barrios, Luis Varela, M.D., 174, 175
Baylor, Elgin, 94Belitnikoff, Fred, 99, 100
Bell, Sam, 125, 126, 127
Bennett, Charles C., 108–109
Bennett, Norman, M.D., 71
Bernadow, Maria E.M., M.D., 169
Bernath, Zoltain, M.D., 71
Bevil, Jack, M.D., 185
Bone cancer, 194. See also
 Cancer, DMSO and. Bonker, Congressman Don, 162
Breast cancer, 61. See also
 Cancer, DMSO and. British Journal of Dermatology
, 63
Brobyn, Richard D., M.D., 80–81
Bronchiolitis, DMSO and, 215–216
Bruises. See
 Musculoskeletal injuries, DMSO and. Buc, Nancy L., 231, 239, 240
Bunions. See
 Foot and leg problems, DMSO and. Burdach, Rodolfo, M.D., 215
Burns, DMSO and, 57–58, 66, 127
Bursitis, DMSO and, 2, 3, 17, 26, 44, 50
calcified, 91–92
Bush, George, 249
Calluses. See
 Foot and leg problems, DMSO and. Camp, Dr. Perry E., 51–52
Cancer, DMSO and, 46, 60–63
anti-cancer solution, 200, 205, 206–207
chemotherapy and DMSO, 148
DMSO-cancer connection, 177–207
DMSO-hematoxylon solution, 185, 192–199, 206–207
DMSO-hematoxylon studies, 179–183, 184–185, 202, 205
orthomolecular therapy, 62
See also
 individual cancers. Capdeville, Lucila, M.D., 168
Carrizo, A., M.D., 181
Cataracts. See
 Eye problems, DMSO and. Cervical cancer, 53, 54, 198–199, 215. See also
 Cancer, DMSO and. Cervical os, stenosis of the, 1–2Chacon, Ernesto, M.D., 71
Chicago Tribune
, 19
Clinical Orthopaedics & Related Research
, 60
Clinical Pharmacology and Therapeutics
, 63
Clubnails. See
 Foot and leg problems, DMSO and. Colon cancer, 177. See also
 Cancer, DMSO and. Commercial Laboratories of Florida, 45
Consumer Reports
, 75
Coping With Cancer
, 207
Corneal swelling. See
 Eye problems, DMSO and. Corns. See
 Foot and leg problems, DMSO and. CREST syndrome. See
 Scleroderma, DMSO and. Crichtlow, Dr. James, 20
Crout, Richard J., M.D., 7, 8, 9, 10, 27, 73, 74, 75, 90, 247
Crown Zellerbach Paper Company, 15, 33, 73
Cystic mastitis, DMSO and, 72
Daily News
, New York, 52
Dancer’s foot. See
 Foot and leg problems, DMSO and. Davidson, Ben, 99
Davis, Orville J., M.D., 215
De Coriat, Lydia F., M.D., 164
De la Torre, Jack C., M.D., 54–55, 81, 82, 127, 147, 148, 149, 150, 152, 153,
154, 157, 242–243
DeLuca, Michael A., M.D., 90
Denehy, Bill, 93–95
Dermatologische Monatsschrift
, 243
Diabetes, DMSO and, 63–64
diabetic ulcers, 67–68
juvenile diabetes, 64, 205
Dimethyl Sulfoxide Technical Bulletin
, 33
Dimethyl sulfoxide (DMSO)
antifungal, antibacterial, and antiviral properties of, 58–59
brand name preparations of Dekaris, 220
Dimexid, 220, 244 87–2, 224
Ipran, 218, 219Plus-Par, 216, 218, 219
Rimso-50, 45, 242
Satori, 230
drug transport properties of, 38–39
FDA and, 7, 8, 9, 10, 13, 16–18, 19, 20, 21, 22, 23, 25, 26, 27, 
28, 29, 39, 42,
52, 72, 73, 75, 78–80, 88, 89–90, 109, 128, 129, 147, 163, 174, 179, 205,
228, 229, 230, 232, 233, 234, 235, 236, 247, 248–249
healing power of, 35–37
infectious diseases and, 209–221. See also
 AIDS; Leprosy; Orchitis;
Osteomyelitis; Parasitic worms; Respiratory infections. media exposure for, 26–30. See also
 60 Minutes. medical uses for, general, 50–72. See also
 individual illness or injury. molecular structure of, 32–35
nontechnical summary, 37–38
origin of, 4, 14–16
pharmacological actions of, 39–42
protection against radiation, freezing, and thawing, 53–54
side effects of, 83–90
suppliers of, 45–46
therapeutic principle of, 31–46
topical administration of, 43–44
DMSO Society of Florida, Inc., 110, 147
Douglass, Dr. William Campbell, 48, 58, 62, 210, 211
Douglass Center for Nutrition and Preventive Medicine, 31, 47, 48
Down’s syndrome, 26, 146, 159–166, 173. See also
 Mental disabilities, DMSO
and. Drachman, Daniel B., M.D., 155
Dry socket, DMSO and, 72
Duncan, Congressman Robert, 88
Dunne, Richard E. III, 242
Ear infections, DMSO and, 59
Edwards, Charles C., M.D. 18
Engel, Marvin F., M.D., 227–228
E.R. Squibb and Sons, 80, 128, 180
Eye problems, DMSO and, 68–69
cataracts, 26, 68–69corneal swelling, 68
glaucoma, 68–69
lens changes from DMSO, 78–83, 228–237
macular degeneration, 68, 69
macular edema, 68
retinitis pigmentosa, 69
traumatic uveitis, 68
Facial cancer, 194. See also
 Cancer, DMSO and. Fallen arches. See
 Foot and leg problems, DMSO and. Federal Register
, 17
Fibrosarcoma, 180, 182, 184. See also
 Cancer, DMSO and. Fil’iula, Dr., 57
Florida legislature and DMSO, 22–23, 24
Florida Medical Association and DMSO, 23–25, 111
Foot and leg problems, DMSO and, 125–142
ankle sprains, 141–142
arthritis of the feet, 131–132
athlete’s foot, 137–138
big toe bunions, 129–130
calluses, 133–134
clubnails, 135–136
corns, 133
dancer’s foot, 139
fallen arches, 140
foot odor, 138
fungus toenails, 136–137
hammertoes, 130–131
heel spurs, 128, 140–141
ingrown toenails, 134–135
metatarsalgia, 139–140
plantar warts, 134
Fractures. See
 Musculoskeletal injuries, DMSO and. Franklin, Murray, M.D., 3, 4
Friend, Charlotte, M.D., 61
Garrido, Jorge Cornejo, 61Gastrointestinal cancer, 193. See also
 Cancer, DMSO and. Geigy, 128
Geller, Jay, 13
Gibb Pharmaceutical Company, 16, 17
Gibson, Merle L., M.D., 230
Giller, Ana, M.D., 169
Glaucoma. See
 Eye problems, DMSO and. Glozman, Dr. V.N., 221
Good Morning America
, 73, 75, 78, 90
Gout, DMSO and, 44, 122
Granulomatosis, 180. See also
 Cancer, DMSO and. Goyan, Jere, PhD, 18, 228, 230, 233, 248
Greccos, George, M.D., 143, 145
Grismali, Jorge, M.D., 174, 175
Growth, Morgan, 125, 126
Gum disease. See
 Periodontal disease, DMSO and. Hallamendaris, Val, 101, 102
Hammertoes. See
 Foot and leg problems, DMSO and. Harmon, Robert L., 87
Harris, Wade, M.D., 177, 178
Hartman, David, 73, 74
Haynie, Louis, 231
Hatch, Orrin G., 125
Hatfield, Senator Mark O., 21
Head and spinal cord injuries, DMSO and, 54–55, 143 154
brain embolism, 150–152
brain trauma and stroke, 55–56, 152–154
brain-damaged children, 56
central nervous system trauma, 157
emergency therapeutic principle, 149–150
intracranial hypertension, 156
myasthenia gravis, 154–155
neurological disorders, 147–149
Headache, DMSO and, 64–65
temporal arteritis, 64
Heart attacks, DMSO and, 72HeLa cells, 199–200
Heel spurs. See
 Foot and leg problems, DMSO and. Hensley, Michael J., M.D., 229, 230, 232, 233, 234, 235
Herpes simplex I, DMSO and, 5, 26, 59, 214–215
DMSO-idoxuridine treatment for, 214
Herpes simplex II, DMSO and, 5, 215
vitamin C-DMSO treatment for, 215
Herpes zoster, DMSO and, 5, 17, 26, 42, 50, 59, 65–66, 209–213, 216
idoxuridine-DMSO treatment for, 211
vitamin C-DMSO treatment for, 215
Herschler, Robert, 15, 73, 74, 78, 87, 224
Hill, Robert V., M.D., 69
Hives, resulting from DMSO treatment, 89
Hoffman, Norman, 125, 126
Horn, Daryll, 126, 127
Howell, James T., M.D., 25–26
Ingrown toenails. See
 Foot and leg problems, DMSO and. Interferon, 180
International Surgery
, 181
Interstitial cystitis, DMSO and, 7, 19, 25, 39, 42, 232, 233, 234, 235, 244–245
Jacob, Stanley W., M.D., 9, 10, 13–14, 15, 16, 28, 29, 31, 35, 37, 40, 43, 51, 55,
57, 61, 79, 88, 91, 92–93, 94, 101, 125, 126, 129, 146, 147, 160, 162, 170, 224,
225, 229, 230, 231, 232
resolving DMSO scandal, 239–243
summary of Jacob and DMSO, 237–239
Jones, June III, 91–92, 98, 99
Journal of the American Geriatrics Society
, 67
Journal of Clinical Oncology
, 4, 62
Journal of Toxicology and Environmental Health
, 82, 242
Journal of Urology
, 245
Kajihara, K., Dr., 150
Kawanaga, Henry, Dr., 150
Keating, Tom, 99
Keloids, DMSO and, 57–58Kelsey, Francis, 73, 78
Kennedy, Marion A., 161
Kennedy, Senator Edward M., 22, 29, 125, 224, 229, 233, 235, 236, 238, 239, 242
Kessler, David, M.D., J.D., 249
Kidney cancer, 63. See also
 Cancer, DMSO and. Krippaehne, William W., M.D., 240
Lagos, Raul Escobar, M.D., 61
Lamonica, Daryle, 99, 101–102
Leiomyosarcoma, 184. See also
 Cancer, DMSO and. Lens changes from DMSO. See
 Eye problems, DMSO and. Leprosy, DMSO and, 220
Letterer-Siwe disease, 205
Leukopenia, 195. See also
 Cancer, DMSO and. Lim, Ramon, M.D., 148
Listook, Dr. Alan B., 13, 231
Liver cancer, 194. See also
 Cancer, DMSO and. Lonborg, Jim, 94
Lucas, Jerry, 94
Ludwig, Dorothy S., 58
Lumbar disc problems, DMSO and, 56–57. See also
 Back pain, DMSO and. Lung cancer, 63, 193. See also
 Cancer, DMSO and. Lung infections, DMSO and, 59
Lymphosarcoma, 182–183, 184, 195–198, 260. See also
 Cancer, DMSO and. Macular degeneration. See
 Eye problems, DMSO and. Macular edema. See
 Eye problems, DMSO and. Malpractice and Confessions of a Medical Heretic
, 123
Manner, Harold W., PhD, 115
Manner Clinic, 118, 119
Manner Clinic Metabolic Research Foundation, 115
M.D. Anderson Cancer Institute, 178, 205
Medical Letter, The
, 53
Medical World News
, 106
Melanoma, 180, 183. See also
 Cancer, DMSO and.
Dmso_Nature_s_Healer_-_Morton_Walker.txt
Summarize the following text section accurately and concisely. Maintain specific details and numerical information, and use anti-repetition mechanisms:

        (P)
423 South PalmPecos, TX 79772
(915) 445-9090
AC,AU,CT,FP,NT,PM
Plano
Linda Martin, D. O. (P)
Suite C
1524 Independence
Plano, TX 75075
(214) 985-1377
FAX (214) 612-0747
CT,GP,NT,PM
San Antonio
Jim P. Archer, D.
1524 Independence Avenue, Plano, TX 75075
What is the address of the office of Linda Martin, D.O. in Plano, TX?
R.B. Allen, M.D.
Which doctor is listed as working in Donvale, Victoria, Australia?
American College of Advancement in Medicine
What is the name of the medical society mentioned in the text?
T. Tsuchiva, K. Kuga, T. Fujishiro, S. Murai, and N. Funahashi
Who is the author of the article "Dimethyl sulfoxide in the treatment of acute, odontogenic inflammatory jaw diseases"?
There is no doctor listed as working in Toronto, Canada.
What is the name of the doctor listed as working in Toronto, Canada?